Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | Defining lymphoma reservoirs

Jessica Okosun • 24 Aug 2020
Follicular Lymphoma Lymphoma

Jessica Okosun, MA, MB, BChir, PhD, MRCP, FRCPath, Barts Cancer Institute, London, UK, discusses one of the key clinical challenges for indolent lymphomas – relapse following initial treatment response. Ongoing research has shown that following induction treatment a minimal residual disease population or lymphoma reservoir is left behind. Research into the biology of these reservoirs is vital to move towards preventing further relapse or transformation, particularly in follicular lymphoma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Jessica Okosun

Early screening in lymphoma: current perspectives & future outlooks
Jessica Okosun et al. • 25 Mar 2024
3:46
The relevance of follicular lymphoma pathogenesis in clinical practice
Jessica Okosun • 6 Sep 2021
2:13
MRD for decision making in follicular lymphoma
Jessica Okosun • 6 Sep 2021
1:47
The influence of the TME on progression and outcomes in follicular lymphoma
Jessica Okosun • 6 Sep 2021

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals